Recent progress in biomaterials-driven ferroptosis for cancer therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Ferroptosis is a programmed cell death characterized by lipid peroxidation, crucial in cancer biology.
• Existing ferroptosis-targeting drugs face challenges with selectivity and pharmacokinetics, limiting clinical use.
• Nanomaterials and hydrogels show promise for enhanced ferroptosis induction in tumors.

Purpose of the Study:

• To review biomedical nanomaterials, particularly hydrogels, for ferroptosis-based cancer therapy.
• To summarize the mechanisms and applications of nanomaterials in ferroptosis.
• To discuss future opportunities and challenges in this therapeutic area.

Main Methods:

• Literature review of ferroptosis mechanisms and nanomaterial applications.
• Categorization and analysis of various nanomaterials used in ferroptosis.
• Discussion of hydrogels as controlled-release drug delivery systems for ferroptosis.

Main Results:

• Ferroptosis research has advanced significantly, with nanotechnology offering new therapeutic avenues.
• Nanomaterials, including hydrogels, enable targeted delivery and controlled release of ferroptosis inducers.
• These approaches aim to increase drug potency and reduce adverse effects in cancer treatment.

Conclusions:

• Biomedical nanomaterials present a promising strategy for overcoming limitations in ferroptosis-driven cancer therapy.
• Further development is needed to address challenges and realize the full potential of these materials.
• This review provides a foundation for future research and clinical translation.